Tag | Content |
---|
EnhancerAtlas ID | HS197-17489 |
Organism | Homo sapiens |
Tissue/cell | ZR75-30 |
Coordinate | chr5:141403470-141405500 |
Target genes | Number: 11 | Name | Ensembl ID |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
MIXL1 | MA0662.1 | chr5:141404845-141404855 | TCTAATTAAC | + | 6.02 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_18492 | chr5:141403709-141405710 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19850 | chr5:141404018-141405589 | CD4p_CD25-_Il17p_PMAstim_Th17 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH05I142024 | chr5 | 141403938 | 141405365 |
|
Enhancer Sequence | CACGAGCAGG ACTGCCAATA CCTTCCATAG GATCATTGAG GCTTTGCTTC AACTCAAATA 60 AATAGTGTAC TTGTAAGCAT ACATCCAACA AAAGTTCTAT TTGTATTATT TCCAACGAAA 120 GCAGTAAAAA CGTTTTCATT AACTGCCAAC TCAAGAGGCT CTGCAAATAT TTGCTATTGT 180 TTCTGAAGTC TCACCTGGAA GGGATTCTAC CTGCAATTGC CTTGTTGCAA GTGTTTTTAT 240 GAGAAAACTA GTGCGCGCAG GAAAAGTTGT ACCTGTATTG TGATACTTGT ATTGTGGCTA 300 TGCCACAAAA AGATGAGGCA TTTAGATATT TGATAATCTC TGTAATAATA AATGAAGCTA 360 TTATATTTTT TATTAGGGCA GTCGATTTTA TCCTAGCATT TGAAATTTTG CTTGCAATTT 420 TGGAACCAGA AAATACTTTG TCAGTAGTAT GTTCAAATAG TTATTTGAGC AGAAAGACTG 480 ATAATGATAT AGTGTGGAAG GCCATTACAA CTTCTATTAC AACTATTTTT GTCTTAATCT 540 GAGTTTCTCT TAATCAAAAA ACTTTGTTGG TGTATCACTT TTCTTAGTAC TGGTTGAGAA 600 AATCTTACAT CTCTTTTATG TTTAGCCATT CATATATGCT AGTTTCCATC TAACTTTCTA 660 TCATTTTTAT ACTAAATGAA CAATTACTGC ACAAAGAGCT TCAAAAGGAC TTTTCCTTGT 720 TTAATAAATG TCCACTGGTC AGAAATTTCA TCACAAAATT TACACTTGCT TTTTGACAAT 780 CAGTGGTTCA AATATACGCA AATAAAAAAC AGATCATATA AACTACTGCA AAAATGGAAG 840 ACTGACTTTG CTAAGCTCAG CCGCTTCAGT ACATCTGTCA CTCGTAAGTC CAAACTCATA 900 ACAAACCATA AACAAGGTCC AACTGTTAAA AGAGTTGCGT TACATTGAAC CTGACATCTG 960 ATGCCAAAAG AAAAAAAAAG TGAACTTCCG GTTTGCTTGC AAGAGAGAAC CGTACCTCTA 1020 TGGGAAAGTC TCCCAACCCC CAGGGCTGAT TTAGTGTAAG GTTTAGGGAA GCGGGTCATG 1080 CAGGGTCTGG TGGCGCTTCT GAAGCCTAAG TATTTAGGAA TCTAAGGCCT TTCAGCTGTG 1140 TTAGCAAATC ACAGGCGGAG GCTGCCTTTC GCCTCCGACT TCCGGGAGCG CCGGCGCTAG 1200 AGCGAGACAC TTGCTCATTG GCTGCTGTCG AGCAGCGGAG GGGACCGAGG GGCCGGCCCT 1260 GATGCGCTGC CTTTCGGGCT GTAGTGGATC CGCTTACTTT TAGGAGTGCA GTTACTGCAG 1320 CGATGCTGTC GCCGACTGGC TGATTTTCAG AACGTGTGTA TGATTAGAAG TTATCTCTAA 1380 TTAACGGTGG CTCCTGTTCA TGACTTTGGG CTTCTGCAAA GAACAGTGTT TTCCTTTCCC 1440 GAATAAAAAA ATAAGTACCC TTAATTCTCA GTCTTCCCTT CTGTTCTTCC CTCAGCCGAA 1500 CCTGCATGAA ACCAAGAAGG TATTGTCCAA ATCTTTATGG AGATACGCTT TTCAGCTAGT 1560 GTTGCCATTT AGGTGATTTA ATTTAGGTGC CAGTTACTGT CGAGGAAAAG TAGCTCTGAT 1620 GATTTTTGAA TGTATTGAAA AAAGCTGAAC ACAGGACATT CAAGGAGTCT TGACAAAGTC 1680 AAGTAGACAA AATACAGGAT GTGCCCCACA TACACAGCCA ACTCTATGGG GAAAGTGAGA 1740 CGGGAAGGGA GGGAAAGCCC CATATCCGAC AGAAAGAAAT CTAAGTCCTT TGTCTTTCTG 1800 GAAGGGCATC CATGGCATCC CGGCTTGTTA AAGAAAAATA TTAGAACAAC CTAAATATCC 1860 GTCAATCAGG GACTGATTGA ATAGTTTTGC ACACTTGTAA AATGGAATAC AATGCAGCTA 1920 CTAAAAAGGA GCCAGTTCCA TGAGCTGATA GGAAGACTAC CACAATAGTT AAATAAATTT 1980 TTAAAAGCAA GATACAGAAC TCCGTATAAC ATGTGTGCTA AAACATGCAT 2030
|